These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 38434979

  • 21. Identification and validation of tryptophan metabolism-related lncRNAs in lung adenocarcinoma prognosis and immune response.
    Gao M, Wang M, Chen Y, Wu J, Zhou S, He W, Shu Y, Wang X.
    J Cancer Res Clin Oncol; 2024 Apr 01; 150(4):171. PubMed ID: 38558328
    [Abstract] [Full Text] [Related]

  • 22. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z, Zhang X, Chen D, Li Z, Wu X, Wang J, Deng Y.
    Front Immunol; 2021 Apr 01; 12():806189. PubMed ID: 35095893
    [Abstract] [Full Text] [Related]

  • 23. A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma.
    Liu Y, Jiang J.
    Cancer Biomark; 2023 Apr 01; 37(1):13-26. PubMed ID: 37005878
    [Abstract] [Full Text] [Related]

  • 24. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma.
    Huang E, Ma T, Zhou J, Ma N, Yang W, Liu C, Hou Z, Chen S, de Castria TB, Zeng B, Zong Z, Zhou T.
    Ann Transl Med; 2022 Jul 01; 10(14):766. PubMed ID: 35965795
    [Abstract] [Full Text] [Related]

  • 25. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma.
    Huang Y, Li X, Chen W, He Y, Wu S, Li X, Hou B, Wang S, He Y, Jiang H, Lun Y, Zhang J.
    Int Immunopharmacol; 2021 Dec 01; 101(Pt B):108286. PubMed ID: 34735975
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X, Wang L, Tu J, Pan X, Li Y, Yin H, Wang M, Yuan X.
    Crit Rev Eukaryot Gene Expr; 2022 Dec 01; 32(1):79-98. PubMed ID: 35377983
    [Abstract] [Full Text] [Related]

  • 29. Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma.
    Li D, Jin S, Chen P, Zhang Y, Li Y, Zhong C, Fan X, Lin H.
    Front Immunol; 2022 Dec 01; 13():991604. PubMed ID: 36685508
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment.
    Cao PW, Liu L, Li ZH, Cao F, Liu FB.
    Front Genet; 2022 Dec 01; 13():853471. PubMed ID: 35547245
    [Abstract] [Full Text] [Related]

  • 35. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J, He Z, Huang Y, Luan T, Chen Z, Wang J, Ding M.
    Dis Markers; 2022 Dec 01; 2022():5204831. PubMed ID: 35664432
    [Abstract] [Full Text] [Related]

  • 36. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL, Zhu ZM.
    Bioengineered; 2021 Dec 01; 12(1):1708-1724. PubMed ID: 33955330
    [Abstract] [Full Text] [Related]

  • 37. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L, Xiao K, Dong Z, Meng T, Cheng X, Xu Y.
    J Cancer Res Clin Oncol; 2023 Sep 01; 149(12):10543-10559. PubMed ID: 37291405
    [Abstract] [Full Text] [Related]

  • 38. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S, Chen W, Wang Y, Zhang Y, Xia R, Shen J, Gong X, Liang Y, Xu J, Tang H, Zhao T, Zhang Y, Chen T, Wang C.
    BMC Cancer; 2022 Jul 01; 22(1):721. PubMed ID: 35778697
    [Abstract] [Full Text] [Related]

  • 39. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.
    Zou R, Liu Y, Qiu S, Lu Y, Chen Y, Yu H, Zhu H, Zhu W, Zhu L, Feng J, Han J.
    Cancer Biomark; 2023 Jul 01; 38(4):551-566. PubMed ID: 38007640
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.